MedPath

SKYCLARYS

SKYCLARYS

Approved
DIN Number

02556219

Drug Class

Human

Market Date

May 29, 2025

Company
HC

Biogen Canada Inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02556219
AIG Number0166624001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
N07XX OTHER NERVOUS SYSTEM DRUGS
Product Specifications
Dosage FormCapsule
Route of AdministrationOral
AHFS Classification92:92.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

OMAVELOXOLONEActive
Strength: 50 MG
Monograph: OMAVELOXOLONE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.